# ABILIFY ASIMTUFII
> **NDA217006** · New Drug Application · Sponsor: OTSUKA · Approved 2023-04-27
## Drug
- **FDA Application Number:** NDA217006
- **Application type:** New Drug Application
- **Brand name:** ABILIFY ASIMTUFII
- **Generic name:** ARIPIPRAZOLE
- **Active ingredients:** ARIPIPRAZOLE
- **Dosage form:** SUSPENSION, EXTENDED RELEASE
- **Route:** INTRAMUSCULAR
- **Marketing status:** Prescription
- **Sponsor:** OTSUKA
- **Manufacturer:** Otsuka America Pharmaceutical, Inc
- **First approval:** 2023-04-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217006)
---
*MORVS · CC0 1.0*